Lipid nanoparticle-delivered ornithine transcarbamylase mRNA alleviates liver fibrosis in preclinical models

鸟氨酸转氨酶 纤维化 医学 信使核糖核酸 内分泌学 药理学 内科学 鸟氨酸转氨酶缺乏症 鸟氨酸氨甲酰转移酶 癌症研究 肝纤维化 肝纤维化 化学
作者
Dongqing Zhai,Jiaping Ni,Xianyu Shao,Weijun Zhao,Yuenan Chen,Kailin Fan,Jingtong Li,Yumeng Shen,Ang Lin,Weiwei Hu,Yijun Yang
出处
期刊:Hepatology [Lippincott Williams & Wilkins]
被引量:3
标识
DOI:10.1097/hep.0000000000001708
摘要

BACKGROUND AND AIMS: Liver fibrosis poses a major health threat globally, with an acute shortage of effective treatments to stop or reverse its progression. Hepatocyte injury serves as the primary cause of liver fibrosis, and restoring the expression of damaged proteins via mRNA delivery represents a promising therapeutic strategy. Clinical studies and animal models have demonstrated that mitochondrial ornithine transcarbamylase ( OTC ) deficiency correlates with increased incidence of liver fibrosis. In this study, we examined the therapeutic potential of OTC mRNA delivery for liver fibrosis. APPROACH AND RESULTS: Analysis of OTC expression and distribution in liver fibrosis revealed significant downregulation in fibrotic tissues. Restoring OTC expression in hepatocytes through AAV8-TBG-OTC significantly inhibits the progression of liver fibrosis. OTC mRNA sequences were developed using a codon-optimization artificial intelligence (AI) tool and synthesized with N1-methylpseudouridine modification, followed by encapsulation into lipid nanoparticle (LNP). Repeated in vivo delivery of OTC mRNA-LNP induced a robust inhibition of fibrogenesis in multiple mouse liver fibrosis models. Mechanistically, restoring OTC mRNA expression significantly recovers impaired mitochondrial and hepatocyte functions, while concurrently inhibiting paracrine ammonia-induced activation of HSCs and macrophages. OTC mRNA significantly suppresses collagen deposition, while the THR- β agonist Resmetirom potently inhibits lipid accumulation; the combination exhibits potent complementary efficacy against metabolic dysfunction-associated steatohepatitis (MASH) liver fibrosis. CONCLUSIONS: Collectively, our study provides the first direct preclinical evidence supporting OTC mRNA therapeutics for treating liver fibrosis and establishes proof-of-concept for mRNA therapy as a novel strategy to reverse liver fibrosis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
超级丸子完成签到,获得积分10
刚刚
优秀念柏完成签到,获得积分10
1秒前
1秒前
墨染完成签到,获得积分10
1秒前
研友_OWE完成签到,获得积分10
1秒前
凡人修仙传完成签到,获得积分10
1秒前
snow完成签到 ,获得积分10
2秒前
2秒前
Lucas的应助被碎觉觉采纳,获得10
2秒前
NexusExplorer的应助被Jenny采纳,获得10
2秒前
jerry完成签到,获得积分10
2秒前
可期完成签到,获得积分10
2秒前
完美世界的应助被今天采纳,获得10
2秒前
2秒前
hongzhihu发布了新的文献求助10
3秒前
一手灵魂完成签到,获得积分10
3秒前
别摆烂了完成签到,获得积分10
4秒前
Cc发布了新的文献求助10
4秒前
艺2333完成签到,获得积分10
4秒前
平常的夜安完成签到,获得积分20
4秒前
炙热觅海完成签到,获得积分10
4秒前
5秒前
6秒前
yuhanli给yuhanli的求助进行了留言
7秒前
潆星发布了新的文献求助10
7秒前
如水从平完成签到,获得积分10
7秒前
书意完成签到 ,获得积分10
7秒前
aaa发布了新的文献求助10
8秒前
cdercder的应助被单纯之柔采纳,获得10
8秒前
yichen发布了新的文献求助10
8秒前
NexusExplorer的应助被武陵济世采纳,获得10
8秒前
靖松完成签到,获得积分10
8秒前
藉河西风完成签到,获得积分10
8秒前
9秒前
Owen的应助被沉静的弼采纳,获得10
9秒前
FashionBoy的应助被石榴采纳,获得10
9秒前
9秒前
结实涵柏完成签到 ,获得积分10
9秒前
qingzhiwu完成签到,获得积分10
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180586
求助须知:如何正确求助?哪些是违规求助? 9570581
关于积分的说明 21813457
捐赠科研通 7776777
什么是DOI,文献DOI怎么找? 3433294
关于科研通互助平台的介绍 2557547
邀请新用户注册赠送积分活动 2479253